If you have received a vaccination, hip replacement or chemotherapy without suffering toxic shock, chances are you have benefited from a vast bloodletting of horseshoe crabs.
https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png00Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2019-08-01 02:05:122019-08-01 13:18:30Blue-blooded crabs at heart of pharma dispute on drug testing